Skip to content

Insider · CIK 0002063957

Ron M Philip

director

Files at AVTX (Avalo Therapeutics, Inc.), HRMY (Harmony Biosciences Holdings, Inc.). First filing -, latest -.

Ron M Philip files SEC Form 4 as director at AVTX (Avalo Therapeutics, Inc.), and also at HRMY (Harmony Biosciences Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Ron M Philip has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 6 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026AVTX
Avalo Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+1,109$12.29$14k1,10911 d ago
Jun 30, 2026AVTX
Avalo Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+69$15.04$1,03869Jul 2, 2026
Jun 23, 2026AVTX
Avalo Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+40,200$0.00$040,200Jun 25, 2026
May 14, 2026HRMY
Harmony Biosciences Holdings, Inc.
AGrant or award
Stock Optionderivative
+21,872$0.00$021,872May 18, 2026
May 15, 2025HRMY
Harmony Biosciences Holdings, Inc.
AGrant or award
Stock Optionderivative
+14,522$0.00$014,522May 16, 2025
Apr 2, 2025HRMY
Harmony Biosciences Holdings, Inc.
AGrant or award
Stock Optionderivative
+14,077$0.00$014,077Apr 4, 2025

Questions about Ron M Philip

Answered from the filings on this page, as of the latest one.

Is Ron M Philip buying or selling?

Ron M Philip has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Ron M Philip's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ron M Philip has 0.

Where does Ron M Philip file Form 4?

Ron M Philip has filed Form 4 at AVTX (Avalo Therapeutics, Inc.); HRMY (Harmony Biosciences Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ron M Philip: insider trades and track record | InsiderTell